Body mass index and breast cancer survival: a Mendelian randomization analysis.
International Journal of Epidemiology.
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus.
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
British Journal of Cancer.
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.
Breast Cancer Research.
MOESM1 of Prediction and clinical utility of a contralateral breast cancer risk model.
MOESM2 of Prediction and clinical utility of a contralateral breast cancer risk model.
hide from search
Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1.
American Journal of Human Genetics.